Publikationen in Zusammenarbeit mit Forschern von Novartis (Sweden) (7)

2014

  1. The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression

    Neuropsychopharmacology, Vol. 39, Núm. 11, pp. 2673-2680

2003

  1. Aminopeptidase activity in renovascular hypertension

    Medical Science Monitor, Vol. 9, Núm. 1

  2. Angiotensinase activities in the kidney of renovascular hypertensive rats

    Peptides, Vol. 24, Núm. 5, pp. 755-760

  3. Angiotensinase activity in hypothalamus and pituitary of hypothyroid, euthyroid and hyperthyroid adult male rats

    Hormone and Metabolic Research, Vol. 35, Núm. 5, pp. 279-281

2001

  1. Aminopeptidase activities after water deprivation in male and female rats

    Regulatory Peptides, Vol. 101, Núm. 1-3, pp. 189-194

  2. Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats

    Hormone and Metabolic Research, Vol. 33, Núm. 9, pp. 559-563

2000

  1. Oral administration of losartan influences aminopeptidase activity in the frontal cortex

    European Neuropsychopharmacology, Vol. 10, Núm. 4, pp. 279-282